Web Stats Provided By Google Analytics

Tuesday, February 13, 2018

CymaBay Therapeutics (CBAY) Reaches New 52-Week High Following Insider Buying Activity

... Management Inc. purchased a new stake in CymaBay Therapeutics in the fourth quarter worth $115,000. Finally, Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% in the second quarter. Ardsley Advisory Partners now owns 50,210 ...
https://sportsperspectives.com/2018/02/13/cymabay-therapeutics-cbay-reaches-new-52-week-high-following-insider-buying-activity.html

No comments:

Post a Comment

Popular Ardsley Roundup Posts